Plasma cell leukemia: a retrospective study of 10 cases

Indian J Cancer. 2014 Jan-Mar;51(1):18-9. doi: 10.4103/0019-509X.134605.

Abstract

Background: Plasma cell leukemia (PCL) is a rare aggressive variant of multiple myeloma (MM) characterized by a fulminant course and poor prognosis. Flow cytometry (FCM) is very useful in the diagnosis of the plasma cell leukemia. Herein, we present 10 cases of PCL.

Materials and methods: We retrospectively studied immunophenotypic profile of 10 cases of PCL from Jan 2009 to Dec 2013 using 5 parameters, 6 color flow cytometric analysis. We also studied their clinical presentation and other laboratory findings.

Results: Common clinical features at presentation were weakness, bone pain, anemia, thrombocytopenia and osteolytic lesions. Plasma cell population were identified by strong expression of CD38 and co-expression of CD38 and CD138. CD56 was expressed in 20% cases. CD19 and CD117 were negative in all cases.

Conclusions: Immunophenotyping is highly useful to differentiate PCL from other chronic lymphoproliferative disorders with plasmacytoid morphology as well as from non-neoplastic reactive plasma cells. Co-expression of CD38 and CD138 is a best combination to identify the plasma cells by using FCM.

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Flow Cytometry
  • Follow-Up Studies
  • Humans
  • Immunophenotyping
  • Leukemia, Plasma Cell / diagnosis*
  • Leukemia, Plasma Cell / immunology
  • Prognosis
  • Retrospective Studies

Substances

  • Biomarkers, Tumor